Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration.

Published in:

Oncologist, 2017, v. 22, n. 4, p. 416, doi. 10.1634/theoncologist.2016-0310

By:

• Elvin, Julia A.;
• Gay, Laurie M.;
• Ort, Rita;
• Shuluk, Joseph;
• Long, Jennifer;
• Shelley, Lauren;
• Lee, Ronald;
• Chalmers, Zachary R.;
• Frampton, Garrett M.;
• Ali, Siraj M.;
• Schrock, Alexa B.;
• Miller, Vincent A.;
• Stephens, Philip J.;
• Ross, Jeffrey S.;
• Frank, Richard

Publication type:

Article